RUNX1 and acute myeloid leukemia: Importantly, among these H + patients, seven were negative for the six prognostically informative AML mutations (FLT3-ITD, NPM1, biallelic CEBPA, ASXL1, RUNX1, and TP53) (Fig. 5b).